| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.681 | 0.008 | 0.76 | 5 Hydroxytryptamine release stimulant | 0.63 0.012 DBMET03303 0.76 0.004 DBMET03305 0.63 0.012 DBMET03306 0.727 0.005 DBMET03304 | DBMET03305 | |
| 0.612 | 0.004 | 0.637 | Cyclic AMP phosphodiesterase inhibitor | 0.637 0.004 DBMET03303 0.236 0.071 DBMET03305 0.637 0.004 DBMET03306 0.26 0.059 DBMET03304 | DBMET03306 | |
| 0.482 | 0.035 | 0.7 | Aldehyde oxidase inhibitor | 0.63 0.015 DBMET03303 0.587 0.021 DBMET03305 0.63 0.015 DBMET03306 0.7 0.008 DBMET03304 | DBMET03304 | |
| 0.469 | 0.028 | 0.537 | Spasmolytic | 0.537 0.019 DBMET03303 0.434 0.034 DBMET03305 0.537 0.019 DBMET03306 0.496 0.023 DBMET03304 | DBMET03306 | |
| 0.437 | 0.018 | 0.449 | Vasodilator | 0.449 0.016 DBMET03303 0.194 0.109 DBMET03305 0.449 0.016 DBMET03306 0.235 0.079 DBMET03304 | DBMET03306 | |
| 0.427 | 0.009 | 0.427 | Thrombolytic | 0.419 0.01 DBMET03303 0.419 0.01 DBMET03306 0.129 0.1 DBMET03304 | ||
| 0.443 | 0.042 | 0.472 | Vasodilator, peripheral | 0.472 0.034 DBMET03303 0.42 0.049 DBMET03305 0.472 0.034 DBMET03306 0.453 0.04 DBMET03304 | DBMET03306 | |
| 0.405 | 0.018 | 0.448 | Platelet aggregation inhibitor | 0.321 0.031 DBMET03303 0.448 0.014 DBMET03305 0.321 0.031 DBMET03306 0.368 0.023 DBMET03304 | DBMET03305 | |
| 0.394 | 0.009 | 0.525 | Tyrosine 3 hydroxylase inhibitor | 0.479 0.004 DBMET03303 0.427 0.006 DBMET03305 0.479 0.004 DBMET03306 0.525 0.004 DBMET03304 | DBMET03304 | |
| 0.392 | 0.028 | 0.701 | Superoxide dismutase inhibitor | 0.495 0.013 DBMET03303 0.589 0.007 DBMET03305 0.495 0.013 DBMET03306 0.701 0.004 DBMET03304 | DBMET03304 | |
| 0.412 | 0.069 | 0.468 | Histamine release inhibitor | 0.468 0.042 DBMET03303 0.468 0.042 DBMET03306 0.251 0.154 DBMET03304 | DBMET03306 | |
| 0.354 | 0.047 | 0.414 | Calcium channel activator | 0.315 0.078 DBMET03303 0.414 0.02 DBMET03305 0.315 0.078 DBMET03306 0.375 0.035 DBMET03304 | DBMET03305 | |
| 0.334 | 0.082 | 0.451 | Transcription factor NF kappa B inhibitor | 0.451 0.053 DBMET03303 0.247 0.13 DBMET03305 0.451 0.053 DBMET03306 0.344 0.079 DBMET03304 | DBMET03306 | |
| 0.323 | 0.075 | 0.364 | Antithrombotic | 0.364 0.06 DBMET03303 0.276 0.106 DBMET03305 0.364 0.06 DBMET03306 0.304 0.085 DBMET03304 | DBMET03306 | |
| 0.352 | 0.114 | 0.352 | 5 Hydroxytryptamine release inhibitor | 0.322 0.141 DBMET03303 0.341 0.123 DBMET03305 0.322 0.141 DBMET03306 0.312 0.152 DBMET03304 | ||
| 0.265 | 0.03 | 0.265 | Focal adhesion kinase 2 inhibitor | 0.208 0.063 DBMET03303 0.208 0.063 DBMET03306 | ||
| 0.31 | 0.079 | 0.432 | Vasodilator, coronary | 0.325 0.069 DBMET03303 0.413 0.031 DBMET03305 0.325 0.069 DBMET03306 0.432 0.027 DBMET03304 | DBMET03304 | |
| 0.245 | 0.017 | 0.245 | Platelet activating factor beta antagonist | 0.164 0.033 DBMET03303 0.164 0.033 DBMET03306 | ||
| 0.238 | 0.018 | 0.238 | Platelet activating factor antagonist | 0.155 0.042 DBMET03303 0.215 0.023 DBMET03305 0.155 0.042 DBMET03306 0.144 0.048 DBMET03304 | ||
| 0.221 | 0.007 | 0.221 | Platelet growth factor antagonist | 0.177 0.012 DBMET03303 0.177 0.012 DBMET03306 | ||
| 0.223 | 0.01 | 0.223 | Phosphodiesterase IV inhibitor | 0.143 0.024 DBMET03303 0.143 0.024 DBMET03306 | ||
| 0.213 | 0.004 | 0.22 | Plasminogen activator inhibitor antagonist | 0.22 0.004 DBMET03303 0.22 0.004 DBMET03306 | DBMET03306 | |
| 0.207 | 0.011 | 0.24 | Adenylate cyclase stimulant | 0.24 0.005 DBMET03303 0.198 0.014 DBMET03305 0.24 0.005 DBMET03306 0.23 0.005 DBMET03304 | DBMET03306 | |
| 0.356 | 0.168 | 0.448 | Antiinflammatory | 0.448 0.111 DBMET03303 0.448 0.111 DBMET03306 | DBMET03306 | |
| 0.234 | 0.045 | 0.266 | Nitric-oxide synthase stimulant | 0.254 0.029 DBMET03303 0.244 0.036 DBMET03305 0.254 0.029 DBMET03306 0.266 0.023 DBMET03304 | DBMET03304 | |
| 0.235 | 0.06 | 0.235 | ErbB-1 antagonist | 0.216 0.074 DBMET03303 0.2 0.089 DBMET03305 0.216 0.074 DBMET03306 0.188 0.104 DBMET03304 | ||
| 0.247 | 0.076 | 0.348 | Tumour necrosis factor alpha release inhibitor | 0.266 0.068 DBMET03303 0.344 0.039 DBMET03305 0.266 0.068 DBMET03306 0.348 0.038 DBMET03304 | DBMET03304 | |
| 0.325 | 0.155 | 0.417 | Apoptosis agonist | 0.417 0.106 DBMET03303 0.417 0.106 DBMET03306 0.324 0.156 DBMET03304 | DBMET03306 | |
| 0.313 | 0.146 | 0.44 | Calcium channel L-type activator | 0.345 0.121 DBMET03303 0.431 0.061 DBMET03305 0.345 0.121 DBMET03306 0.44 0.056 DBMET03304 | DBMET03304 | |
| 0.205 | 0.043 | 0.459 | Amylase inhibitor | 0.286 0.02 DBMET03303 0.335 0.014 DBMET03305 0.286 0.02 DBMET03306 0.459 0.007 DBMET03304 | DBMET03304 | |
| 0.17 | 0.01 | 0.17 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.164 0.011 DBMET03303 0.164 0.011 DBMET03306 | ||
| 0.167 | 0.013 | 0.167 | CDC-like kinase 3 inhibitor | 0.157 0.016 DBMET03303 0.157 0.016 DBMET03306 | ||
| 0.24 | 0.091 | 0.265 | 5 Hydroxytryptamine uptake stimulant | 0.264 0.068 DBMET03303 0.24 0.091 DBMET03305 0.264 0.068 DBMET03306 0.265 0.067 DBMET03304 | DBMET03304 | |
| 0.204 | 0.056 | 0.204 | 5 Hydroxytryptamine 3E antagonist | 0.197 0.068 DBMET03305 | ||
| 0.183 | 0.037 | 0.188 | Anesthetic local | 0.17 0.041 DBMET03303 0.188 0.036 DBMET03305 0.17 0.041 DBMET03306 0.175 0.039 DBMET03304 | DBMET03305 | |
| 0.2 | 0.055 | 0.264 | Mcl-1 antagonist | 0.264 0.031 DBMET03303 0.264 0.031 DBMET03306 | DBMET03306 | |
| 0.181 | 0.044 | 0.221 | Tubulin antagonist | 0.221 0.031 DBMET03303 0.158 0.054 DBMET03305 0.221 0.031 DBMET03306 0.197 0.038 DBMET03304 | DBMET03306 | |
| 0.183 | 0.047 | 0.207 | MAO inhibitor | 0.207 0.039 DBMET03303 0.207 0.039 DBMET03306 | DBMET03306 | |
| 0.311 | 0.182 | 0.398 | Caspase 9 stimulant | 0.367 0.133 DBMET03303 0.337 0.157 DBMET03305 0.367 0.133 DBMET03306 0.398 0.112 DBMET03304 | DBMET03304 | |
| 0.174 | 0.047 | 0.174 | GABA C receptor rho-2 antagonist | 0.155 0.068 DBMET03303 0.143 0.084 DBMET03305 0.155 0.068 DBMET03306 0.126 0.114 DBMET03304 | ||
| 0.223 | 0.1 | 0.33 | Interleukin agonist | 0.243 0.084 DBMET03303 0.311 0.043 DBMET03305 0.243 0.084 DBMET03306 0.33 0.035 DBMET03304 | DBMET03304 | |
| 0.195 | 0.078 | 0.214 | Insulin sensitizer | 0.214 0.06 DBMET03303 0.181 0.094 DBMET03305 0.214 0.06 DBMET03306 0.2 0.073 DBMET03304 | DBMET03306 | |
| 0.192 | 0.085 | 0.241 | Neurotrophic factor enhancer | 0.241 0.044 DBMET03303 0.179 0.099 DBMET03305 0.241 0.044 DBMET03306 0.228 0.053 DBMET03304 | DBMET03306 | |
| 0.183 | 0.078 | 0.252 | DNA methyltransferase I inhibitor | 0.252 0.046 DBMET03303 0.133 0.126 DBMET03305 0.252 0.046 DBMET03306 0.181 0.08 DBMET03304 | DBMET03306 | |
| 0.176 | 0.071 | 0.291 | Tumour necrosis factor antagonist | 0.157 0.092 DBMET03303 0.291 0.02 DBMET03305 0.157 0.092 DBMET03306 0.263 0.027 DBMET03304 | DBMET03305 | |
| 0.136 | 0.032 | 0.136 | CDK2/cyclin A inhibitor | 0.121 0.041 DBMET03303 0.121 0.041 DBMET03306 | ||
| 0.185 | 0.084 | 0.186 | Death-associated protein kinase 3 inhibitor | 0.186 0.083 DBMET03303 0.186 0.083 DBMET03306 | DBMET03306 | |
| 0.167 | 0.067 | 0.168 | Neurotensin receptor agonist | 0.168 0.065 DBMET03303 0.142 0.124 DBMET03305 0.168 0.065 DBMET03306 0.143 0.12 DBMET03304 | DBMET03306 | |
| 0.187 | 0.089 | 0.196 | Histone acetyltransferase inhibitor | 0.196 0.075 DBMET03303 0.196 0.075 DBMET03306 | DBMET03306 | |
| 0.16 | 0.063 | 0.16 | CDC-like kinase 1 inhibitor | 0.138 0.079 DBMET03303 0.138 0.079 DBMET03306 | ||
| 0.18 | 0.089 | 0.333 | Amyloid beta aggregation inhibitor | 0.333 0.038 DBMET03303 0.333 0.038 DBMET03306 0.238 0.062 DBMET03304 | DBMET03306 | |
| 0.165 | 0.076 | 0.191 | Death-associated protein kinase 2 inhibitor | 0.191 0.042 DBMET03303 0.191 0.042 DBMET03306 | DBMET03306 | |
| 0.181 | 0.093 | 0.235 | DNA methylase inhibitor | 0.235 0.057 DBMET03303 0.135 0.133 DBMET03305 0.235 0.057 DBMET03306 0.189 0.087 DBMET03304 | DBMET03306 | |
| 0.124 | 0.037 | 0.173 | HIV-1 integrase (Overall Integration) inhibitor | 0.173 0.018 DBMET03303 0.107 0.049 DBMET03305 0.173 0.018 DBMET03306 0.152 0.025 DBMET03304 | DBMET03306 | |
| 0.171 | 0.083 | 0.171 | MAP kinase kinase 5 inhibitor | 0.156 0.13 DBMET03303 0.156 0.13 DBMET03306 | ||
| 0.152 | 0.067 | 0.239 | Lipid peroxidase inhibitor | 0.239 0.029 DBMET03303 0.239 0.029 DBMET03306 0.174 0.053 DBMET03304 | DBMET03306 | |
| 0.129 | 0.046 | 0.14 | MAO B inhibitor | 0.14 0.041 DBMET03303 0.14 0.041 DBMET03306 | DBMET03306 | |
| 0.14 | 0.058 | 0.14 | Vascular endothelial growth factor antagonist | 0.092 0.09 DBMET03303 0.092 0.09 DBMET03306 | ||
| 0.224 | 0.143 | 0.224 | Angiogenesis inhibitor | 0.218 0.15 DBMET03303 0.218 0.15 DBMET03306 | ||
| 0.15 | 0.069 | 0.192 | Protein kinase stimulant | 0.192 0.045 DBMET03303 0.192 0.045 DBMET03306 | DBMET03306 | |
| 0.1 | 0.022 | 0.1 | Phosphodiesterase III inhibitor | 0.086 0.031 DBMET03303 0.064 0.048 DBMET03305 0.086 0.031 DBMET03306 | ||
| 0.112 | 0.035 | 0.112 | Histamine H1 receptor antagonist | 0.071 0.068 DBMET03303 0.079 0.059 DBMET03305 0.071 0.068 DBMET03306 | ||
| 0.154 | 0.077 | 0.154 | Anticoagulant | 0.143 0.087 DBMET03303 0.143 0.087 DBMET03306 | ||
| 0.135 | 0.058 | 0.158 | Vanilloid 1 agonist | 0.158 0.031 DBMET03303 0.158 0.031 DBMET03306 0.131 0.065 DBMET03304 | DBMET03306 | |
| 0.1 | 0.024 | 0.11 | Estrogen-related receptor beta agonist | 0.11 0.015 DBMET03303 0.08 0.068 DBMET03305 0.11 0.015 DBMET03306 0.087 0.046 DBMET03304 | DBMET03306 | |
| 0.212 | 0.138 | 0.33 | 12-Lipoxygenase inhibitor | 0.33 0.065 DBMET03303 0.33 0.065 DBMET03306 0.235 0.119 DBMET03304 | DBMET03306 | |
| 0.15 | 0.076 | 0.15 | Cholinergic | 0.13 0.096 DBMET03303 0.126 0.101 DBMET03305 0.13 0.096 DBMET03306 | ||
| 0.255 | 0.184 | 0.393 | Alpha-glucosidase inhibitor | 0.393 0.118 DBMET03303 0.393 0.118 DBMET03306 | DBMET03306 | |
| 0.136 | 0.065 | 0.136 | Acetylcholinesterase inhibitor | 0.13 0.069 DBMET03303 0.103 0.1 DBMET03305 0.13 0.069 DBMET03306 | ||
| 0.077 | 0.007 | 0.121 | Dopamine D5 agonist | 0.121 0.003 DBMET03303 0.073 0.008 DBMET03305 0.121 0.003 DBMET03306 0.116 0.004 DBMET03304 | DBMET03306 | |
| 0.136 | 0.068 | 0.136 | Phosphodiesterase inhibitor | |||
| 0.112 | 0.047 | 0.112 | Antihistaminic | 0.099 0.055 DBMET03305 | ||
| 0.084 | 0.024 | 0.093 | 5 Hydroxytryptamine 2A agonist | 0.059 0.048 DBMET03303 0.093 0.018 DBMET03305 0.059 0.048 DBMET03306 0.07 0.037 DBMET03304 | DBMET03305 | |
| 0.129 | 0.072 | 0.193 | NADPH oxidase inhibitor | 0.193 0.037 DBMET03303 0.193 0.037 DBMET03306 | DBMET03306 | |
| 0.132 | 0.075 | 0.167 | Toll-Like receptor 9 antagonist | 0.167 0.052 DBMET03305 0.117 0.089 DBMET03304 | DBMET03305 | |
| 0.159 | 0.103 | 0.26 | P-glycoprotein inhibitor | 0.164 0.096 DBMET03303 0.26 0.038 DBMET03305 0.164 0.096 DBMET03306 0.252 0.041 DBMET03304 | DBMET03305 | |
| 0.144 | 0.089 | 0.144 | Sigma receptor agonist | 0.124 0.109 DBMET03303 0.124 0.109 DBMET03306 | ||
| 0.101 | 0.047 | 0.101 | Histamine antagonist | 0.09 0.055 DBMET03305 | ||
| 0.132 | 0.077 | 0.132 | Death-associated protein kinase 1 inhibitor | 0.124 0.1 DBMET03303 0.124 0.1 DBMET03306 | ||
| 0.124 | 0.07 | 0.124 | Cholinergic antagonist | 0.113 0.08 DBMET03303 0.109 0.085 DBMET03305 0.113 0.08 DBMET03306 0.099 0.097 DBMET03304 | ||
| 0.112 | 0.064 | 0.112 | Vascular endothelial growth factor 2 antagonist | |||
| 0.107 | 0.06 | 0.133 | MAO A inhibitor | 0.133 0.047 DBMET03303 0.133 0.047 DBMET03306 | DBMET03306 | |
| 0.099 | 0.054 | 0.106 | Phosphodiesterase 6D inhibitor | 0.106 0.042 DBMET03303 0.106 0.042 DBMET03306 0.089 0.079 DBMET03304 | DBMET03306 | |
| 0.136 | 0.091 | 0.139 | Ca2+-transporting ATPase inhibitor | 0.139 0.079 DBMET03303 0.134 0.099 DBMET03305 0.139 0.079 DBMET03306 0.137 0.087 DBMET03304 | DBMET03306 | |
| 0.103 | 0.058 | 0.103 | GABA C receptor rho-1 antagonist | 0.089 0.08 DBMET03303 0.093 0.073 DBMET03305 0.089 0.08 DBMET03306 | ||
| 0.141 | 0.099 | 0.16 | Arachidonic acid antagonist | 0.16 0.076 DBMET03303 0.136 0.105 DBMET03305 0.16 0.076 DBMET03306 0.156 0.081 DBMET03304 | DBMET03306 | |
| 0.06 | 0.017 | 0.06 | Potassium channel small-conductance Ca-activated blocker | 0.053 0.022 DBMET03305 | ||
| 0.198 | 0.158 | 0.25 | Prostaglandin dehydrogenase inhibitor | 0.25 0.126 DBMET03303 0.25 0.126 DBMET03306 | DBMET03306 | |
| 0.108 | 0.067 | 0.108 | GABA C receptor antagonist | 0.104 0.072 DBMET03303 0.095 0.086 DBMET03305 0.104 0.072 DBMET03306 | ||
| 0.108 | 0.068 | 0.108 | Polo-like kinase-4 inhibitor | 0.09 0.088 DBMET03303 0.09 0.088 DBMET03306 | ||
| 0.096 | 0.057 | 0.096 | Toll-Like receptor 3 antagonist | |||
| 0.096 | 0.058 | 0.096 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.146 | 0.108 | 0.146 | 3C-like protease (Human coronavirus) inhibitor | 0.145 0.109 DBMET03305 | ||
| 0.106 | 0.069 | 0.106 | Electron transport complex I inhibitor | 0.106 0.07 DBMET03303 0.098 0.087 DBMET03305 0.106 0.07 DBMET03306 0.099 0.085 DBMET03304 | ||
| 0.089 | 0.053 | 0.098 | Granulocyte macrophage colony stimulating factor agonist | 0.098 0.038 DBMET03303 0.083 0.068 DBMET03305 0.098 0.038 DBMET03306 0.09 0.05 DBMET03304 | DBMET03306 | |
| 0.072 | 0.035 | 0.155 | Beta adrenoreceptor antagonist | 0.096 0.018 DBMET03303 0.122 0.01 DBMET03305 0.096 0.018 DBMET03306 0.155 0.005 DBMET03304 | DBMET03304 | |
| 0.096 | 0.059 | 0.103 | Breast cancer-resistant protein inhibitor | 0.1 0.055 DBMET03303 0.1 0.056 DBMET03305 0.1 0.055 DBMET03306 0.103 0.052 DBMET03304 | DBMET03304 | |
| 0.125 | 0.089 | 0.125 | Vascular endothelial growth factor 3 antagonist | |||
| 0.137 | 0.101 | 0.174 | Melanin inhibitor | 0.174 0.056 DBMET03303 0.174 0.056 DBMET03306 0.126 0.122 DBMET03304 | DBMET03306 | |
| 0.123 | 0.089 | 0.126 | Sphingosine 1-phosphate receptor 2 antagonist | 0.126 0.081 DBMET03303 0.126 0.081 DBMET03306 0.115 0.109 DBMET03304 | DBMET03306 | |
| 0.06 | 0.027 | 0.063 | Nicotinic alpha3beta2 receptor antagonist | 0.063 0.023 DBMET03305 0.049 0.047 DBMET03304 | DBMET03305 | |
| 0.109 | 0.076 | 0.113 | Sphingosine 1-phosphate receptor 2 agonist | 0.113 0.067 DBMET03305 0.103 0.093 DBMET03304 | DBMET03305 | |
| 0.048 | 0.016 | 0.081 | Phenylethanolamine N methyltransferase inhibitor | 0.046 0.019 DBMET03303 0.081 0.004 DBMET03305 0.046 0.019 DBMET03306 0.075 0.004 DBMET03304 | DBMET03305 | |
| 0.151 | 0.119 | 0.158 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.158 0.113 DBMET03303 0.158 0.113 DBMET03306 | DBMET03306 | |
| 0.046 | 0.014 | 0.046 | Estrogen-related receptor alpha antagonist | 0.043 0.016 DBMET03303 0.043 0.016 DBMET03306 | ||
| 0.096 | 0.065 | 0.096 | Butyrylcholinesterase inhibitor | 0.085 0.076 DBMET03303 0.085 0.076 DBMET03306 | ||
| 0.065 | 0.034 | 0.082 | Potassium channel (Ca-activated) blocker | 0.082 0.017 DBMET03305 0.059 0.044 DBMET03304 | DBMET03305 | |
| 0.046 | 0.017 | 0.046 | 5 Hydroxytryptamine 2B agonist | 0.046 0.016 DBMET03305 | ||
| 0.217 | 0.187 | 0.217 | GABA C receptor rho-3 antagonist | |||
| 0.118 | 0.088 | 0.121 | Toll-Like receptor antagonist | 0.121 0.083 DBMET03303 0.117 0.088 DBMET03305 0.121 0.083 DBMET03306 0.121 0.083 DBMET03304 | DBMET03304 | |
| 0.099 | 0.07 | 0.099 | Factor V inhibitor | 0.093 0.089 DBMET03303 0.093 0.089 DBMET03306 | ||
| 0.106 | 0.077 | 0.107 | TRPA1 agonist | 0.107 0.076 DBMET03303 0.107 0.076 DBMET03306 | DBMET03306 | |
| 0.125 | 0.096 | 0.137 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.137 0.087 DBMET03303 0.137 0.087 DBMET03306 | DBMET03306 | |
| 0.056 | 0.028 | 0.056 | Alpha 1L adrenoreceptor antagonist | 0.05 0.044 DBMET03303 0.052 0.037 DBMET03305 0.05 0.044 DBMET03306 | ||
| 0.102 | 0.074 | 0.185 | Monophenol monooxygenase inhibitor | 0.185 0.037 DBMET03303 0.185 0.037 DBMET03306 | DBMET03306 | |
| 0.058 | 0.032 | 0.058 | Myc inhibitor | 0.051 0.043 DBMET03303 0.051 0.043 DBMET03306 | ||
| 0.254 | 0.228 | 0.254 | MAP kinase 1 inhibitor | |||
| 0.063 | 0.038 | 0.104 | Beta tubulin antagonist | 0.104 0.021 DBMET03303 0.056 0.042 DBMET03305 0.104 0.021 DBMET03306 0.095 0.024 DBMET03304 | DBMET03306 | |
| 0.035 | 0.011 | 0.035 | Thiazolidinedione | 0.032 0.015 DBMET03303 0.032 0.015 DBMET03306 | ||
| 0.079 | 0.055 | 0.138 | Acetylcholine nicotinic antagonist | 0.138 0.024 DBMET03305 0.099 0.04 DBMET03304 | DBMET03305 | |
| 0.09 | 0.067 | 0.157 | Prolactin inhibitor | 0.113 0.043 DBMET03303 0.129 0.033 DBMET03305 0.113 0.043 DBMET03306 0.157 0.019 DBMET03304 | DBMET03304 | |
| 0.143 | 0.121 | 0.247 | Anesthetic general | 0.161 0.102 DBMET03303 0.223 0.063 DBMET03305 0.161 0.102 DBMET03306 0.247 0.052 DBMET03304 | DBMET03304 | |
| 0.104 | 0.084 | 0.11 | Microtubule formation inhibitor | 0.11 0.074 DBMET03303 0.098 0.095 DBMET03305 0.11 0.074 DBMET03306 0.104 0.083 DBMET03304 | DBMET03306 | |
| 0.143 | 0.125 | 0.168 | Succinate dehydrogenase inhibitor | 0.168 0.083 DBMET03303 0.14 0.133 DBMET03305 0.168 0.083 DBMET03306 0.164 0.089 DBMET03304 | DBMET03306 | |
| 0.079 | 0.064 | 0.113 | Calcium antagonist | 0.113 0.039 DBMET03305 | DBMET03305 | |
| 0.126 | 0.111 | 0.128 | Sphingosine 1-phosphate receptor 5 antagonist | 0.128 0.106 DBMET03303 0.128 0.106 DBMET03306 | DBMET03306 | |
| 0.093 | 0.078 | 0.093 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.166 | 0.152 | 0.215 | Hypoglycemic | 0.215 0.099 DBMET03303 0.215 0.099 DBMET03306 0.204 0.109 DBMET03304 | DBMET03306 | |
| 0.058 | 0.045 | 0.058 | Alpha 2 adrenoreceptor agonist | 0.056 0.048 DBMET03303 0.056 0.048 DBMET03306 | ||
| 0.129 | 0.117 | 0.188 | Dual specificity phosphatase 3 inhibitor | 0.188 0.068 DBMET03303 0.188 0.068 DBMET03306 | DBMET03306 | |
| 0.087 | 0.076 | 0.113 | Sphingomyelinase inhibitor | 0.113 0.047 DBMET03305 0.091 0.071 DBMET03304 | DBMET03305 | |
| 0.063 | 0.052 | 0.063 | Acetylcholine M5 receptor agonist | 0.058 0.057 DBMET03305 | ||
| 0.187 | 0.177 | 0.292 | Insulysin inhibitor | 0.213 0.138 DBMET03303 0.266 0.082 DBMET03305 0.213 0.138 DBMET03306 0.292 0.063 DBMET03304 | DBMET03304 | |
| 0.05 | 0.041 | 0.081 | Alpha tubulin antagonist | 0.079 0.02 DBMET03303 0.053 0.037 DBMET03305 0.079 0.02 DBMET03306 0.081 0.019 DBMET03304 | DBMET03304 | |
| 0.065 | 0.056 | 0.108 | Histidine decarboxylase inhibitor | 0.108 0.029 DBMET03303 0.108 0.029 DBMET03306 0.095 0.034 DBMET03304 | DBMET03306 | |
| 0.028 | 0.02 | 0.045 | Nicotinic alpha4beta2 receptor agonist | 0.045 0.005 DBMET03305 0.03 0.017 DBMET03304 | DBMET03305 | |
| 0.082 | 0.074 | 0.1 | ATPase (Vacuolar H+) inhibitor | 0.096 0.045 DBMET03303 0.087 0.061 DBMET03305 0.096 0.045 DBMET03306 0.1 0.04 DBMET03304 | DBMET03304 | |
| 0.056 | 0.048 | 0.056 | Phosphodiesterase 1B inhibitor | |||
| 0.019 | 0.012 | 0.019 | Alpha 2c adrenoreceptor agonist | |||
| 0.146 | 0.14 | 0.18 | Dyrk kinase inhibitor | 0.18 0.111 DBMET03303 0.18 0.111 DBMET03306 | DBMET03306 | |
| 0.057 | 0.05 | 0.057 | Phosphodiesterase 1A inhibitor | |||
| 0.149 | 0.144 | 0.205 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.205 0.097 DBMET03303 0.205 0.097 DBMET03306 | DBMET03306 | |
| 0.128 | 0.123 | 0.174 | Dual specificity phosphatase inhibitor | 0.174 0.071 DBMET03303 0.174 0.071 DBMET03306 | DBMET03306 | |
| 0.052 | 0.048 | 0.052 | 5 Hydroxytryptamine 7 agonist | |||
| 0.073 | 0.069 | 0.073 | ALK inhibitor | |||
| 0.04 | 0.036 | 0.061 | 5 Hydroxytryptamine 2C agonist | 0.061 0.02 DBMET03305 0.041 0.035 DBMET03304 | DBMET03305 | |
| 0.141 | 0.139 | 0.181 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.181 0.105 DBMET03303 0.181 0.105 DBMET03306 | DBMET03306 | |
| 0.1 | 0.098 | 0.1 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.071 | 0.07 | 0.071 | Phosphodiesterase 3A inhibitor | |||
| 0.059 | 0.058 | 0.124 | Beta 3 adrenoreceptor antagonist | 0.074 0.028 DBMET03303 0.089 0.018 DBMET03305 0.074 0.028 DBMET03306 0.124 0.009 DBMET03304 | DBMET03304 | |
| 0.045 | 0.045 | 0.096 | Beta 2 adrenoreceptor antagonist | 0.063 0.022 DBMET03303 0.071 0.016 DBMET03305 0.063 0.022 DBMET03306 0.096 0.008 DBMET03304 | DBMET03304 | |
| 0.088 | 0.089 | 0.119 | Glutamate (mGluR7) agonist | 0.119 0.032 DBMET03305 | DBMET03305 | |
| 0.055 | 0.057 | 0.063 | Bcl-xL inhibitor | 0.063 0.033 DBMET03303 0.063 0.033 DBMET03306 | DBMET03306 | |
| 0.07 | 0.072 | 0.234 | Adrenaline agonist | 0.108 0.032 DBMET03303 0.172 0.01 DBMET03305 0.108 0.032 DBMET03306 0.234 0.005 DBMET03304 | DBMET03304 | |
| 0.048 | 0.05 | 0.093 | Beta 1 adrenoreceptor antagonist | 0.067 0.029 DBMET03303 0.077 0.02 DBMET03305 0.067 0.029 DBMET03306 0.093 0.012 DBMET03304 | DBMET03304 | |
| 0.109 | 0.115 | 0.126 | Papain-like protease (SARS coronavirus) inhibitor | 0.126 0.068 DBMET03303 0.126 0.068 DBMET03306 | DBMET03306 | |
| 0.025 | 0.031 | 0.028 | Estrogen-related receptor gamma antagonist | 0.028 0.021 DBMET03303 0.028 0.021 DBMET03306 | DBMET03306 | |
| 0.122 | 0.129 | 0.141 | Interferon gamma antagonist | 0.141 0.092 DBMET03303 0.141 0.092 DBMET03306 | DBMET03306 | |
| 0.064 | 0.072 | 0.101 | Nicotinic alpha4beta2 receptor antagonist | 0.101 0.031 DBMET03305 | DBMET03305 | |
| 0.099 | 0.107 | 0.178 | Toll-Like receptor 2 antagonist | 0.15 0.053 DBMET03303 0.122 0.075 DBMET03305 0.15 0.053 DBMET03306 0.178 0.035 DBMET03304 | DBMET03304 | |
| 0.003 | 0.014 | 0.006 | Insulin like growth factor 3 antagonist | 0.006 0.004 DBMET03303 0.006 0.004 DBMET03306 | DBMET03306 | |
| 0.04 | 0.052 | 0.059 | 5 Hydroxytryptamine 2 agonist | 0.059 0.028 DBMET03305 | DBMET03305 | |
| 0.053 | 0.065 | 0.091 | Neuronal nicotinic receptor antagonist | 0.091 0.029 DBMET03305 0.064 0.05 DBMET03304 | DBMET03305 | |
| 0.017 | 0.03 | 0.066 | Beta 1 adrenoreceptor agonist | 0.024 0.014 DBMET03303 0.039 0.005 DBMET03305 0.024 0.014 DBMET03306 0.066 0.004 DBMET03304 | DBMET03304 | |
| 0.037 | 0.05 | 0.175 | Dopamine transporter inhibitor | 0.175 0.005 DBMET03305 0.147 0.006 DBMET03304 | DBMET03305 | |
| 0.127 | 0.14 | 0.196 | Pyruvate kinase inhibitor | 0.196 0.083 DBMET03303 0.196 0.083 DBMET03306 | DBMET03306 | |
| 0.043 | 0.058 | 0.048 | Factor III inhibitor | 0.048 0.04 DBMET03303 0.048 0.04 DBMET03306 | DBMET03306 | |
| 0.095 | 0.111 | 0.152 | Cyclooxygenase 3 inhibitor | 0.105 0.096 DBMET03303 0.143 0.054 DBMET03305 0.105 0.096 DBMET03306 0.152 0.046 DBMET03304 | DBMET03304 | |
| 0.064 | 0.081 | 0.085 | Keratolytic | 0.085 0.043 DBMET03303 0.085 0.043 DBMET03306 0.074 0.058 DBMET03304 | DBMET03306 | |
| 0.034 | 0.053 | 0.041 | Dihydroorotase inhibitor | 0.04 0.039 DBMET03305 0.041 0.037 DBMET03304 | DBMET03304 | |
| 0.01 | 0.035 | 0.017 | Nicotinic alpha4 receptor agonist | 0.017 0.01 DBMET03305 | DBMET03305 | |
| 0.091 | 0.117 | 0.103 | Alpha-N-acetylglucosaminidase inhibitor | 0.103 0.098 DBMET03305 0.103 0.098 DBMET03304 | DBMET03304 | |
| 0.063 | 0.089 | 0.096 | Estrogen receptor alpha antagonist | 0.083 0.044 DBMET03303 0.073 0.061 DBMET03305 0.083 0.044 DBMET03306 0.096 0.03 DBMET03304 | DBMET03304 | |
| 0.184 | 0.211 | 0.248 | Sodium/bile acid cotransporter inhibitor | 0.248 0.13 DBMET03303 0.248 0.13 DBMET03306 0.244 0.134 DBMET03304 | DBMET03306 | |
| 0.061 | 0.091 | 0.076 | Androgen antagonist | 0.076 0.07 DBMET03303 0.076 0.07 DBMET03306 | DBMET03306 | |
| 0.124 | 0.158 | 0.14 | ATPase inhibitor | 0.14 0.12 DBMET03303 0.14 0.12 DBMET03306 | DBMET03306 | |
| 0.142 | 0.176 | 0.29 | Antioxidant | 0.29 0.065 DBMET03303 0.29 0.065 DBMET03306 0.271 0.073 DBMET03304 | DBMET03306 | |
| 0.038 | 0.072 | 0.071 | Beta adrenoreceptor agonist | 0.045 0.032 DBMET03303 0.054 0.012 DBMET03305 0.045 0.032 DBMET03306 0.071 0.005 DBMET03304 | DBMET03304 | |
| 0.013 | 0.055 | 0.024 | Dopamine D1 agonist | 0.024 0.014 DBMET03303 0.024 0.014 DBMET03306 0.023 0.015 DBMET03304 | DBMET03306 | |
| 0.12 | 0.163 | 0.153 | Antimitotic | 0.153 0.118 DBMET03303 0.153 0.118 DBMET03306 0.138 0.135 DBMET03304 | DBMET03306 | |
| 0.037 | 0.08 | 0.051 | Nicotinic receptor alpha4 subunit antagonist | 0.051 0.031 DBMET03305 | DBMET03305 | |
| 0.084 | 0.129 | 0.114 | Bone formation stimulant | 0.108 0.098 DBMET03303 0.108 0.098 DBMET03306 0.114 0.091 DBMET03304 | DBMET03304 | |
| 0.052 | 0.098 | 0.069 | Beta 2 adrenoreceptor agonist | 0.061 0.045 DBMET03303 0.06 0.051 DBMET03305 0.061 0.045 DBMET03306 0.069 0.021 DBMET03304 | DBMET03304 | |
| 0.129 | 0.177 | 0.298 | Free radical scavenger | 0.298 0.052 DBMET03303 0.298 0.052 DBMET03306 0.267 0.062 DBMET03304 | DBMET03306 | |
| 0.152 | 0.201 | 0.254 | Lipoxygenase inhibitor | 0.254 0.098 DBMET03303 0.254 0.098 DBMET03306 | DBMET03306 | |
| 0.122 | 0.172 | 0.134 | Heat shock protein 70 antagonist | 0.134 0.102 DBMET03303 0.134 0.102 DBMET03306 | DBMET03306 | |
| 0.057 | 0.106 | 0.142 | Antiadrenergic | 0.142 0.038 DBMET03305 0.134 0.041 DBMET03304 | DBMET03305 | |
| 0.019 | 0.07 | 0.044 | Histamine H3 receptor antagonist | 0.044 0.031 DBMET03305 | DBMET03305 | |
| 0.067 | 0.119 | 0.185 | Expectorant | 0.094 0.075 DBMET03303 0.134 0.042 DBMET03305 0.094 0.075 DBMET03306 0.185 0.024 DBMET03304 | DBMET03304 | |
| 0.059 | 0.111 | 0.081 | Antineoplastic alkaloid | 0.081 0.065 DBMET03303 0.081 0.065 DBMET03306 | DBMET03306 | |
| 0.062 | 0.114 | 0.088 | Urease inhibitor | 0.088 0.08 DBMET03303 0.088 0.08 DBMET03306 | DBMET03306 | |
| 0.075 | 0.129 | 0.198 | M18 aspartyl aminopeptidase inhibitor | 0.198 0.034 DBMET03303 0.198 0.034 DBMET03306 0.113 0.077 DBMET03304 | DBMET03306 | |
| 0.054 | 0.107 | 0.137 | Adrenaline antagonist | 0.137 0.039 DBMET03305 0.128 0.041 DBMET03304 | DBMET03305 | |
| 0.065 | 0.119 | 0.109 | Creatine kinase inhibitor | 0.109 0.05 DBMET03303 0.109 0.05 DBMET03306 0.091 0.07 DBMET03304 | DBMET03306 | |
| 0.03 | 0.09 | 0.449 | 5 Hydroxytryptamine uptake inhibitor | 0.449 0.004 DBMET03305 0.328 0.005 DBMET03304 | DBMET03305 | |
| 0.027 | 0.087 | 0.058 | Carbonic anhydrase XIV inhibitor | 0.043 0.042 DBMET03305 0.058 0.026 DBMET03304 | DBMET03304 | |
| 0.077 | 0.138 | 0.128 | DOPA decarboxylase inhibitor | 0.105 0.066 DBMET03303 0.096 0.084 DBMET03305 0.105 0.066 DBMET03306 0.128 0.037 DBMET03304 | DBMET03304 | |
| 0.051 | 0.113 | 0.081 | 5 Hydroxytryptamine 2C antagonist | 0.081 0.06 DBMET03305 | DBMET03305 | |
| 0.024 | 0.087 | 0.045 | Aldose reductase inhibitor | 0.045 0.044 DBMET03303 0.045 0.044 DBMET03306 | DBMET03306 | |
| 0.205 | 0.269 | 0.262 | Cyclophilin D inhibitor | 0.262 0.199 DBMET03303 0.262 0.199 DBMET03306 | DBMET03306 | |
| 0.051 | 0.117 | 0.108 | Alpha adrenoreceptor antagonist | 0.108 0.052 DBMET03305 0.091 0.063 DBMET03304 | DBMET03305 | |
| 0.083 | 0.15 | 0.114 | Alkaline phosphatase inhibitor | 0.114 0.094 DBMET03303 0.114 0.094 DBMET03306 | DBMET03306 | |
| 0.057 | 0.125 | 0.098 | Bronchodilator | 0.098 0.066 DBMET03304 | DBMET03304 | |
| 0.051 | 0.119 | 0.143 | Alpha 2 adrenoreceptor antagonist | 0.143 0.029 DBMET03305 0.14 0.03 DBMET03304 | DBMET03305 | |
| 0.018 | 0.088 | 0.048 | Dopamine D2 agonist | 0.048 0.028 DBMET03304 | DBMET03304 | |
| 0.036 | 0.107 | 0.344 | Adrenaline uptake inhibitor | 0.344 0.004 DBMET03305 0.267 0.005 DBMET03304 | DBMET03305 | |
| 0.103 | 0.175 | 0.134 | Amyloid beta precursor protein antagonist | 0.134 0.12 DBMET03303 0.134 0.12 DBMET03306 | DBMET03306 | |
| 0.118 | 0.191 | 0.185 | Antiamyloidogenic | 0.185 0.11 DBMET03303 0.185 0.11 DBMET03306 | DBMET03306 | |
| 0.038 | 0.112 | 0.059 | Sphingosine kinase inhibitor | 0.059 0.04 DBMET03304 | DBMET03304 | |
| 0.037 | 0.111 | 0.074 | Phenylalanine 4-hydroxylase inhibitor | 0.067 0.05 DBMET03303 0.067 0.05 DBMET03306 0.074 0.042 DBMET03304 | DBMET03304 | |
| 0.064 | 0.138 | 0.09 | Carbonic anhydrase III inhibitor | 0.09 0.074 DBMET03303 0.09 0.074 DBMET03306 | DBMET03306 | |
| 0.029 | 0.104 | 0.126 | Dopamine uptake inhibitor | 0.126 0.013 DBMET03305 0.089 0.022 DBMET03304 | DBMET03305 | |
| 0.078 | 0.156 | 0.127 | Estrogen antagonist | 0.117 0.06 DBMET03303 0.117 0.06 DBMET03306 0.127 0.043 DBMET03304 | DBMET03304 | |
| 0.044 | 0.122 | 0.139 | Alpha 2a adrenoreceptor antagonist | 0.125 0.028 DBMET03305 0.139 0.025 DBMET03304 | DBMET03304 | |
| 0.011 | 0.09 | 0.021 | Motilin receptor agonist | 0.021 0.02 DBMET03305 | DBMET03305 | |
| 0.035 | 0.117 | 0.052 | Vanilloid 2 antagonist | 0.052 0.037 DBMET03303 0.052 0.037 DBMET03306 0.049 0.043 DBMET03304 | DBMET03306 | |
| 0.064 | 0.148 | 0.087 | Vanilloid agonist | 0.087 0.053 DBMET03303 0.087 0.053 DBMET03306 | DBMET03306 | |
| 0.067 | 0.153 | 0.115 | Mucolytic | 0.115 0.059 DBMET03304 | DBMET03304 | |
| 0.054 | 0.142 | 0.098 | Histamine H2 receptor antagonist | 0.098 0.036 DBMET03305 | DBMET03305 | |
| 0.092 | 0.181 | 0.136 | Farnesoid X receptor antagonist | 0.122 0.1 DBMET03303 0.122 0.1 DBMET03306 0.136 0.072 DBMET03304 | DBMET03304 | |
| 0.034 | 0.123 | 0.119 | Dopamine D1 antagonist | 0.071 0.039 DBMET03305 0.119 0.02 DBMET03304 | DBMET03304 | |
| 0.025 | 0.115 | 0.069 | NMDA 2C receptor antagonist | 0.067 0.036 DBMET03305 0.069 0.035 DBMET03304 | DBMET03304 | |
| 0.061 | 0.152 | 0.114 | Estrogen receptor beta antagonist | 0.104 0.056 DBMET03303 0.104 0.056 DBMET03306 0.114 0.04 DBMET03304 | DBMET03304 | |
| 0.048 | 0.142 | 0.075 | Carbonic anhydrase VI inhibitor | 0.075 0.064 DBMET03304 | DBMET03304 | |
| 0.032 | 0.128 | 0.076 | HIV-1 integrase (3'-Processing) inhibitor | 0.076 0.036 DBMET03303 0.076 0.036 DBMET03306 | DBMET03306 | |
| 0.05 | 0.146 | 0.106 | 5-Lipoxygenase inhibitor | 0.106 0.059 DBMET03303 0.106 0.059 DBMET03306 | DBMET03306 | |
| 0.064 | 0.165 | 0.105 | Acetylcholine antagonist | 0.105 0.085 DBMET03305 | DBMET03305 | |
| 0.058 | 0.163 | 0.105 | 5 Hydroxytryptamine 2B antagonist | 0.105 0.077 DBMET03305 | DBMET03305 | |
| 0.028 | 0.139 | 0.073 | Dopamine agonist | 0.073 0.042 DBMET03304 | DBMET03304 | |
| 0.04 | 0.15 | 0.073 | Calcium channel L-type blocker | 0.073 0.048 DBMET03305 | DBMET03305 | |
| 0.056 | 0.173 | 0.097 | Nitric-oxide synthase inhibitor | 0.097 0.065 DBMET03305 | DBMET03305 | |
| 0.134 | 0.251 | 0.251 | Cholesterol antagonist | 0.196 0.168 DBMET03305 0.251 0.124 DBMET03304 | DBMET03304 | |
| 0.089 | 0.209 | 0.144 | Nitric oxide antagonist | 0.138 0.108 DBMET03303 0.138 0.108 DBMET03306 0.144 0.1 DBMET03304 | DBMET03304 | |
| 0.013 | 0.138 | 0.06 | Glycine transporter inhibitor | 0.06 0.025 DBMET03305 | DBMET03305 | |
| 0.074 | 0.201 | 0.123 | Protein-tyrosine phosphatase inhibitor | 0.123 0.11 DBMET03303 0.123 0.11 DBMET03306 | DBMET03306 | |
| 0.045 | 0.174 | 0.094 | 5 Hydroxytryptamine 2 antagonist | 0.094 0.077 DBMET03305 | DBMET03305 | |
| 0.039 | 0.168 | 0.082 | Ornithine decarboxylase inhibitor | 0.082 0.065 DBMET03304 | DBMET03304 | |
| 0.044 | 0.176 | 0.074 | Inducible nitric-oxide synthase inhibitor | 0.074 0.073 DBMET03305 | DBMET03305 | |
| 0.021 | 0.155 | 0.054 | HIV-1 integrase (Strand Transfer) inhibitor | 0.054 0.046 DBMET03303 0.054 0.046 DBMET03306 | DBMET03306 | |
| 0.07 | 0.206 | 0.115 | Peroxidase inhibitor | 0.115 0.106 DBMET03303 0.115 0.106 DBMET03306 | DBMET03306 | |
| 0.069 | 0.207 | 0.293 | Psychostimulant | 0.293 0.044 DBMET03305 0.284 0.047 DBMET03304 | DBMET03305 | |
| 0.141 | 0.301 | 0.201 | Caspase 3 stimulant | 0.201 0.168 DBMET03303 0.201 0.168 DBMET03306 | DBMET03306 | |
| 0.018 | 0.182 | 0.062 | Prolyl endopeptidase inhibitor | 0.062 0.022 DBMET03305 0.054 0.031 DBMET03304 | DBMET03305 | |
| 0.051 | 0.217 | 0.107 | Adenylate cyclase inhibitor | 0.107 0.078 DBMET03304 | DBMET03304 | |
| 0.123 | 0.312 | 0.232 | 15-Lipoxygenase inhibitor | 0.23 0.182 DBMET03303 0.23 0.182 DBMET03306 0.232 0.181 DBMET03304 | DBMET03304 | |
| 0.06 | 0.25 | 0.12 | Interleukin 4 antagonist | 0.12 0.085 DBMET03303 0.12 0.085 DBMET03306 | DBMET03306 | |
| 0.128 | 0.332 | 0.2 | Apoptosis antagonist | 0.2 0.179 DBMET03303 0.2 0.179 DBMET03306 0.199 0.181 DBMET03304 | DBMET03306 | |
| 0.008 | 0.225 | 0.035 | Catechol O-methyltransferase inhibitor | 0.03 0.028 DBMET03303 0.03 0.028 DBMET03306 0.035 0.02 DBMET03304 | DBMET03304 | |
| 0.099 | 0.327 | 0.298 | Hypoxia-inducible factor 1 alpha inhibitor | 0.228 0.121 DBMET03305 0.298 0.066 DBMET03304 | DBMET03304 | |
| 0.004 | 0.256 | 0.037 | Growth hormone secretagogue receptor agonist | 0.037 0.023 DBMET03305 | DBMET03305 | |
| 0.064 | 0.322 | 0.137 | Hepatoprotectant | 0.137 0.124 DBMET03304 | DBMET03304 | |
| 0.047 | 0.306 | 0.189 | Angiogenesis stimulant | 0.189 0.1 DBMET03304 | DBMET03304 | |
| 0.041 | 0.371 | 0.263 | Interleukin 1 antagonist | 0.263 0.016 DBMET03305 0.248 0.019 DBMET03304 | DBMET03305 | |
| 0.106 | 0.452 | 0.251 | Interleukin 2 agonist | 0.227 0.147 DBMET03305 0.251 0.117 DBMET03304 | DBMET03304 | |
| 0.07 | 0.435 | 0.131 | MAP kinase kinase 4 inhibitor | 0.131 0.109 DBMET03304 | DBMET03304 | |
| 0.053 | 0.436 | 0.636 | Cardiotonic | 0.636 0.006 DBMET03305 0.587 0.008 DBMET03304 | DBMET03305 | |
| 0.038 | 0.428 | 0.155 | Platelet antagonist | 0.155 0.139 DBMET03304 | DBMET03304 | |
| 0.035 | 0.451 | 0.21 | Interleukin antagonist | 0.178 0.098 DBMET03305 0.21 0.079 DBMET03304 | DBMET03304 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |